Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
Offering SPR-BLI Services - Proteins provided for free!
Get your basement membrane extract free sample to test now!
Time Limited Offer: Welcome Gift for New Customers !
Shipping Price Reduction for EU Regions
>
Kits ELISA de detección de citoquinas
Rápido y fácil de usar: ensayo de 2 horas con sólo 7 pasos necesarios.
Coherente: Calibrado según las normas NIBSC/OMS para garantizar la coherencia entre lotes.
Estricto control de calidad: Alta sensibilidad, especificidad, exactitud, linealidad y precisión inter/intra.
Método validado: Validación completa con protocolo disponible y asistencia técnica profesional las 24 horas.
Interferencia de matriz mínima: Baja interferencia de la matriz verificada en sobrenadante de cultivo celular y suero.
Cat. No. | Product Description |
---|
RUO | PRO | ||
---|---|---|---|
Tiempo de detección | 2-3h | 2h | |
Tipo de muestra | Cell Culture Supernates, Serum , Plasma | Cell Culture Supernates, Serum , Plasma | |
Sistema de gestión de la calidad | ISO13485 | ||
Guía de validación | ICH M10 | ||
Experimento de validación | Efecto gancho | √ | √ |
Efecto matriz | Bilirubin, Hemoglobin, Triglyceride | ||
Efecto anticoagulante | EDTA, Heparin, Sodium citrate | ||
Influencia de las condiciones de almacenamiento de las muestras | 3 Freeze–thaw Cycles | ||
Especificidad | IL-2, IL-4, IL-6, IL-7, IL-10, IL-15, IL-21, IL-1β, TNF-alpha, GM-CSF | IL-1β, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12 p70, IL-13, IL-15, IL-17, GM-CSF, TNF-alpha, IFN-gamma, etc. |
The sensitivity of ClinMax™ Human Interferon-γ (IFN-γ) ELISA Kit (Cat. No. CRS-A017) is 5.309 pg/Ml.
ClinMax™ Human Interferon-γ (IFN-γ) ELISA Kit (Cat. No. CRS-A017) was verified to have an intra/inter-precision of less than 10%.
The sensitivity of ClinMax™ Human IFN-γ ELISA Kit, PRO (Cat. No. CEA-C006) is 3.25 pg/mL.
ClinMax™ Human IFN-γ ELISA Kit, PRO (Cat. No. CEA-C006) was verified to have an intra/inter-precision of less than 10%.
Diseases that are commonly present during sample collection such as jaundice (elevated bilirubin), hemolysis (elevated hemoglobin), and lipemia (elevated triglyceride) were simulated. Bilirubin, hemoglobin, and triglycerides were individually spiked into the sample matrix at a concentration of 20 mg/dL, 3500 g/dL, 2.0 g/L, respectively to evaluate matrix effect on our (XXX) kits.
Anticoagulant effect was tested by spiking the sample with either heparin, EDTA, or sodium citrate at a concentration of 40U/mL, 4mg/mL, and 40mg/mL, respectively.
This web search service is supported by Google Inc.